Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
Sign Up to like & getrecommendations! Published in 2018 at "Radiology"
DOI: 10.1148/radiol.2018180273
Abstract: Purpose To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant chemotherapy for breast cancer. Materials and Methods In this prospective… read more here.
Keywords: treatment; her2 disease; diffusion; breast cancer ... See more keywords
ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-018-7046-9
Abstract: Initially, neoadjuvant chemotherapy (NAC) was predominantly used in locally advanced disease. However, NAC is now considered for any patient who would be recommended adjuvant chemotherapy based on clinical and histological examination at diagnosis. NAC may… read more here.
Keywords: disease; her2 disease; neoadjuvant chemotherapy; use triple ... See more keywords